P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE. (23rd June 2022) - Wang, M.; Mei, M.; Barr, P. M.; Barrientos, J.; de Vos, S.; Furman, R.; Patel, K.; Thompson, P. A.; Choi, M.; Kallam, A.; Zhu, Y.; Chakraborty, S.; et al.